Saudi Arabia Announces 7 New Mining Exploration Licenses for Competition

A mining site in Saudi Arabia (Ministry of Industry’s website)
A mining site in Saudi Arabia (Ministry of Industry’s website)
TT

Saudi Arabia Announces 7 New Mining Exploration Licenses for Competition

A mining site in Saudi Arabia (Ministry of Industry’s website)
A mining site in Saudi Arabia (Ministry of Industry’s website)

The Saudi Ministry of Industry and Mineral Resources has invited both local and international investors to bid for seven new mining exploration licenses in the Makkah region (west of the Kingdom) and the capital Riyadh, covering a total area of 1,070 square kilometers.

This initiative is part of the ministry’s ongoing efforts to accelerate the exploration of the Kingdom’s mineral wealth, in line with the objectives of Vision 2030, which aims to make the mining sector the third pillar of Saudi industry, according to a statement from the ministry.

The ministry explained that the proposed exploration license sites contain valuable mineral resources, including base metals such as gold, copper, zinc, lead, and silver. Four of the sites are located in the Makkah region, including the Wadi Al-Leith site, which spans more than 243 square kilometers and is rich in copper, zinc, and gold.

Additionally, the Jabal Baydan site covers 244 square kilometers and contains deposits of copper, gold, zinc, silver, and lead. The Umm Hajlan - Maamalah site, covering 78 square kilometers, contains copper, lead, and gold deposits. The Jabal Al-Da’ma site, with an area of 210 square kilometers, has deposits of silver, lead, and zinc.

The remaining three sites are located in the Riyadh region. These include the Jabal Al-Khulla - North site, which spans over 98 square kilometers and contains deposits of zinc, silver, and lead, and the Jabal Al-Khulla - South site, covering more than 19 square kilometers with deposits of zinc, lead, and silver. The Jabal Subha site, covering 171 square kilometers, contains deposits of silver, lead, zinc, and cobalt.

The ministry noted that the bidding phase for the exploration licenses began in mid-October and will continue until mid-November. The winners of the seventh round of bidding are expected to be announced in December.

The ministry emphasized that the competition will evaluate the technical competence of the bidders, with 70% of the evaluation criteria focused on work plans and technical ability, while 30% will be based on community contributions and innovation support activities, aligning with the ministry’s principles of governance, transparency, sustainability, and environmental and social responsibility.

The Ministry of Industry and Mineral Resources, in collaboration with the Ministry of Investment, had previously launched a program to empower mining exploration, offering a package of incentives to reduce risks for exploration companies in the early stages of their projects. This is in addition to the incentives provided under the Mining Investment Law, which allows the establishment of 100% foreign-owned companies and offers financing of up to 75% of capital costs.



UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
TT

UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM

Mubadala Investment Company has acquired an 80% stake in Global Medical Supply Chain (GMSC) and Al Ittihad Drug Store (IDS) from GlobalOne Healthcare Holding (GHH), with GHH retaining a 20% stake, Emirates News Agency (WAM) reported on Tuesday.

This strategic acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors, aligning with the UAE's vision to establish a robust life sciences infrastructure, WAM said.

Founded in 2015, GMSC provides comprehensive end-to-end supply chain services for medical products, including demand planning, procurement, logistics, inventory management, warehousing, and maintenance.

GMSC serves over 200 medical facilities, including hospitals and clinics across the UAE. With a dedicated team of medical supply chain specialists, GMSC sources a broad array of products from almost 400 suppliers, ensuring a reliable supply chain for all medical needs.

IDS, established in 1987, stands as one of the leading distributors of pharmaceutical and consumer healthcare products in the UAE. Distributing over 1,000 products from over 40 leading suppliers, IDS services every hospital, and all, or at least most pharmacies and supermarkets within the UAE. It boasts a vast portfolio that spans multiple therapeutic categories including anti-infectives, asthma, diabetes, and oncology.

"The expanding pharmaceutical market drives an increasing demand for specialized and efficient drug logistics solutions. By integrating GMSC and IDS into our portfolio, we are poised to create a vertically integrated life sciences sector in the UAE and enable its potential to encompass the entire value chain from logistics and distribution to specialized manufacturing,” said Executive Director of UAE Clusters at Mubadala's UAE Investments Platform Ismail Ali Abdulla.

As for Low Ping, Group CEO Yas Holding, she said that the transaction “continues Mubadala's strategic growth, following another significant acquisition by its new speciality pharmaceutical business, KELIX bio, which recently acquired a 100% stake in four pharma assets from GlobalOne Healthcare Holding's, the healthcare division of Yas Holding.”

“These concerted efforts underline Mubadala's commitment to strengthening the UAE's healthcare and pharmaceutical sectors as part of broader national ambitions for drug security and economic diversification."

GlobalOne Healthcare Holding LLC serves as the dedicated Healthcare Division of Yas Holding LLC, focusing on enhancing healthcare outcomes by investing in innovative solutions across various healthcare verticals.